期刊文献+

婴幼儿型血管瘤治疗疗效评价方法的研究进展 被引量:1

The advances in evaluation of therapeutic efficacy of Infantile Hemangioma
下载PDF
导出
摘要 婴幼儿型血管瘤(Infantile Hemangioma,IH)是婴幼儿最常见的良性肿瘤之一,目前针对IH的干预措施较多,但对疗效的评价方式缺乏统一标准,存在评价指标主观、片面、单一等缺点,导致难以准确评价治疗后的疗效,影响临床治疗方案的制定。目前评价IH治疗疗效的方法众多,包括瘤体外观法、影像学辅助法、皮温法、精确体积法、体液/生化标志物法等,但各种方法都存在一定不足,本文就目前IH治疗后疗效评价方法的研究进展做一综述。 Infantile Hemangioma (IH) is one of the most common benign tumor in infants and young children.At present,there are many interventions for the treatment of IH,but the evaluation methods of therapeutic efficacy are lack of uniform standard with shortcomings such as subjective,one-sided single index and so on,which cause the uncertainty of the effect of the various treatments and influence clinical decision making.At present,the evaluation methods of the therapeutic efficacy in the treatment of infantile hemangioma are various,including tumor appearance method,imaging assistant method,skin temperature method,accurate volume method,body fluid/biochemical marker method,However,there are some deficiencies in the above methods.This paper reviews the current research advance in the evaluation of the efficacy of IH therapy.
作者 丁辉阳 方军 邓青 徐仙赟 刘潜 DING Hui-yang;FANG Jun;DENG Qing;XU Xian-yun;LIU Qian(Grade 2016,Gannan Medical University,Ganzhou,Jiangxi 341000;Gannan Medical Univercity,Jiangxi 341000)
出处 《赣南医学院学报》 2019年第1期92-96,共5页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 江西省自然科学基金课题(20181BAB205052) 江西省教育厅重点项目(GJJ150936) 江西省青年科学基金课题(20142BAB215025)
关键词 婴幼儿血管瘤 疗效评价 血管瘤活动度评分 血管瘤严重程度量表 Infantile Hemangioma Therapeutic evaluation The Hemangioma Activity Score The Hemangioma Severity Scale
  • 相关文献

参考文献13

二级参考文献106

  • 1魏敬军,王育敏,王嘉军,马新英,关荣.^(32)P治疗体表血管瘤的疗效观察[J].中华皮肤科杂志,2003,36(12):685-686. 被引量:14
  • 2中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组.口腔颌面部血管瘤及脉管畸形的诊断和治疗指南(草案)[J].中华口腔医学杂志,2005,40(3):185-186. 被引量:139
  • 3Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy [J]. N Engl J Med, 2008, 358(24):2649-2651.
  • 4Waner M, Suen J Y. Management of congenital vascular lesions of the head and neck [J]. Oncology(Williston Park), 1995, 9 (10) :989-994, 997.
  • 5Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [J]. N Engl J Med, 1995,333(26) : 1757-1763.
  • 6Jadhav V M, Tolat S N. Dramatic response of propranolol in hemangioma:report of two cases [J]. Indian J Dermatol Venereol Leprol, 2010,76 (6) : 691-694.
  • 7Siegfried E C, Keenan W J, Al-Jureidini S. More on propranolol for hemangiomas of infancy [J]. N Engl J Med, 2008, 359 (26) : 2846-2847.
  • 8Lawley L, Siegfried E. Propranolol treatment for hemangiomas of infancy : risks and recommendations [ J ]. Pediatr Dermatol, 2009, 26(5) :610-614.
  • 9Gclmetti C, Frasin A, Restano L. Innovative therapeutics in pediatric dermatology [J]. Dermatol Clin, 2010, 28(3):619- 629.
  • 10Sans V, de la Roque E D, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report [J]. Pediatrics, 2009,124 ( 3 ) : e423-431.

共引文献51

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部